|
|
|
Introduction
|
|
|
The
majority of patients with fecal incontinence due to a
simple defect of the external anal sphincter will benefit
from direct (overlapping) sphincter repair. Larger
sphincter defects resulting from obstetric, surgical or
other trauma are candidates for new treatment options such
as skeletal muscle transposition (1,2) or the application
of an artificial bowel sphincter (3), which will markedly
improve the situation in up to 75-80% of patients.
However,
a considerable number of patients with severe fecal
incontinence will not show any structural defect of the
external or internal anal sphincter on endo-anal
ultrasonography or magnetic resonance imaging and have
been described as patients with so-called idiopathic
incontinence in the past.
In
this group with primary
degeneration and weakness of the anal sphincter and
the pelvic floor as well as in patients with fecal
incontinence due to spinal
injury and other neurological disorders, treatment
options have been limited so far.
Chronic
sacral nerve stimulation (SNS)
has been proposed for selected forms of non-neurogenic and
neurogenic bladder dysfunction, mainly due to the
reduction of the contractility of the detrusor during
electrostimulation (4,5).
During
stimulation, two different reflex arcs are believed to be
activated via excitation of S2-S4 afferents. Sympathetic
hypogastric activity is increased and parasympathetic
activity of the lower motoneuron of the bladder is reduced.
This dual effect is used for the treatment of detrusor
hyperactivity.
Based
on various studies in the past, SNS is an accepted
treatment
modality for urge incontinence as well as the pelvic pain syndrome (6).
Additionally,
electrostimulation has been extensively researched to
improve micturition in spinal cord patients (7) . Anorectal
side effects during this treatment for urinary
incontinence consisted of an increase in anal sphincter as
well as colonic motility.
In
contrast to the extensive experience gained with SNS for
urologic indications, reports concerning the application
of this modality for fecal incontinence are limited. The
largest series published so far consists of 9 evaluable
patients and was presented by Vaizey and co-workers . The
patients were mainly treated for fecal incontinence due to
weakness of the anal sphincters while one patient was
treated for incontinence following a pull-through
procedure after anal atresia and a
significant reduction of the number of incontinence
episodes was registered in 7 of 9 patients.
Since
intramuscular stimulation of an insufficient anal
sphincter had been attempted as late as in the sixties of
this century , the application of SNS in patients with a
weak anal sphincter or neurologically caused incontinence
seemed to be an interesting new therapeutic approach.
Preliminary reports showed promising data for SNS in
patients with therapy-refractory fecal incontinence,
because of which this treatment was introduced at our
institution.
|
|
|
Preoperative
Evaluation
|
|
All
patients have to undergo extensive pre-operative
evaluation including clinical inspection, the completion of a standardized incontinence diary over a period of three weeks, anal
sphincter manometry and endoanal
ultrasound and/or magnetic resonance imaging.
A
saline retention
test after the application of
saline at a volume causing the first urge for
defecation
is performed and the maximal time span from the end
of instillation to the first evacuation of saline was
documented.
Subjects
are regarded as candidates for SNS if they presented a minimum of one incontinence
episode per week during the three-week observation
period documented in their continence diary. Furthermore, no
structural defects have to be observed in the external
anal sphincter either on endoanal ultrasound or on MRI.
Failed
treatment with a 6-week course in bio-feedback must also
be reported in all patients.
Patients
with neurologically
caused incontinence have to present a minimal
history of one year in order to exclude
patients with a spontaneous recovery following trauma or
spinal cord surgery.
|
|
|
Technique
of sacral nerve stimulation
|
|
|
Under
general or local anesthesia,
four to six needles are positioned into the foramina S2 to S4 bilaterally, and
stimulation is performed by the use of an external pulse
generator (Screener, model 3625, Medtronic, Minneapolis,
Minnesota, USA).

The
muscular response of the pelvic floor and the anal
sphincters is evaluated visually with both buttocks fixed
firmly in order to differentiate pelvic floor response
from a possible gluteal contraction. Additionally,
intraoperative anal manometry or EMG can be
performed.
Following
a positive stimulation response
of the pelvic floor and/or the anal sphincters, the
subsequent procedure of SNS is performed according to the
recommendations for urological indications.
In order to evaluate the functional relevance of positive
electric stimulation, a percutaneous
nerve evaluation (PNE) is performed by application of
a temporary stimulation wire which is introduced into the
stimulation needle and fixed to the skin.
The
functional result of stimulation is recorded over a period
of 10 - 21 days and is followed by a final saline
retention test. Patients whose continence status improves
undergo permanent
implantation of a pulse generator (INTERSTIM,
Medtronic, Kerkrade, Netherlands). During this procedure
the permanent electrode is implanted at the site of the
external stimulation wire and then connected to the
subcutaneous pulse generator by application of an
extension kit.
|
|
|
Recent
results
|
|
|
Acute
(needle) testing revealed a typical positive visual
response (i.e. contraction of the pelvic floor in a
cranial-ventral direction and circular contraction of the
anal sphincter) in 16 patients who underwent
subsequently permanent implantation. In 4 patients
(fecal incontinence following spinal cord trauma after a
car accident: 2 , spinal stroke, and meningomyelocele) the
acute testing failed to show any response. |
|
|
Functional
results
|
|
|
All
patients who had shown a positive visual response during
acute testing and who had received a permanent implant revealed a marked
reduction in their incontinence episodes as well as an
increase in the time span during saline retention tests .
The
median number of incontinence episodes for solid or liquid
stool per 21 days decreased from 6 episodes (3 – 15 / 21
days) to 2 (0
– 5 / 21 days) in the total series of 16 implanted
patients. Patients (n:4) with idiopathic incontinence
revealed 3,3,4,and 6 episodes respectively preoperatively
compared with 0,0,0,
and 2 episodes postoperatively. The median number of
incontinence episodes in neuro patients (n: 12) was
preoperative 7
(4 - 15) and
postoperative 2 (0 – 5) (p < 0.01)
.
The
time period of retention of a
volume of saline causing an urge
until definitive defecation was preoperative 2 min
(0 – 5 min) and raised to 7.5 min ( 2 – 15 min). In
idiopathic patients the preoperative measurements were
2,2,5,and 7 minutes and (postoperative) 2, 10,10,and 15
minutes, respectively.
In
the group with neurological incontinence the preoperative
retention test revealed a median time of
2 min (0-5 min ) compared with 7 min (2 – 15 min)
(p< 0.01)
.
As
the most prominent observation, patients with
neurologically induced incontinence and two patients with
idiopathic incontinence
reported a restoration of their anal sensory
function.
This consisted of an improvement in the sensory capacity
of the rectum ampulla as well as the restoration of
sensory function perianally
and the perineal skin.
This
was nicely shown by two patients in the idiopathic group
who did not report any feeling in the rectum
up to the maximal distension of the balloon (i.e.
300 ml) and who reported a complete recovery of their
sensory function following SNS
Three
patients who had to undergo a complete explant of the
stimulation system due to infections
(one patient with meningomyolocele, one with
Friedreich’s ataxia and one with idiopathic incontinence)
reported an immediate deterioration of their continence
function following explantation of the system. After
of the infectious situation, all of them were rated
as candidates for renewed sacral nerve stimulation. Until
the control date (Mar. 1, 2001) one patient underwent a successful reimplantation
while two others are still waiting for a new SNS. |
|
|
Discussion
|
|
|
Contrary
to other reports, the main indication in our series was
incontinence of neurological origin (n: 15), usually
following spinal cord trauma or as a complication after
spinal cord surgery for protrusion. While 4 patients
showed no pelvic floor and/or anal sphincter response
during acute testing, 15 patients achieved a marked
improvement or even complete restoration of their
continence status, as shown by a reduction in the number
of incontinence episodes per week as well as by an
increase in the retention time.
The
positive stimulation response during acute testing was
confirmed visually by the typical contraction features of
the pelvic floor and the anal sphincters and significant
changes in postoperative anal manometry (3 months
postoperatively) were observed.
We were able to demonstrate a significant increase
in sphincter pressures and anal canal length which we
attribute to the larger number of patients (compared to
previous publications) in our series.
Neuromodulation
of sacral reflexes and regulation of rectal sensitivity
appear to be the major reasons for the functional
improvement in our neurological patients following SNS.
Although difficult to objectify by diagnostic instruments,
all patients showed a successful response, and reported a
marked improvement in their rectal sensory function as
well as in perianal and perineal sensitivity. Especially
in patients following spinal cord trauma in the lumbar
region (L1 to L5) , the notion of overcoming the
neurological defect by a more distally applied stimulation
is a novel approach. Neurophysiologic investigations like
pudendal nerve latency measurement which might be able to
demonstrate the effects of SNS were not performed in our
series. Beside the lack of equipment for these procedures
at our institutions these investigations have always been
restricted to very specialized departments and have been
criticized for
their interobserver variability as well as their limited
clinical relevance.
Our
preliminary experience showed that the surgical management
of patients with fecal incontinence might differ
considerably from that of urological patients. While an
effective influence of SNS on the urinary bladder can only
be evaluated during an observation period of 2-3 weeks
involving repeated measurements of the residual bladder
volume , a typical positive response to external
stimulation during acute testing in fecal incontinence was
associated with improved function in almost all of our
patients reported in this series. Furthermore, 3 patients
developed severe infection of the implanted material,
which led to explantation of the stimulation system
despite a positive influence on continence function; the
infection had probably occurred during the external
stimulation process.
Therefore, we altered our concept to an immediate implant
during a one-stage procedure following a positive pelvic
floor/and or sphincter response after needle stimulation.
Referring
to the concerns regarding the implantation of a
cost-intensive system and the potentially inadequate
functional outcome, it should be emphasized that all
patients in the present series had severe fecal
incontinence that was therapy refractory to other
treatment modalities. In the past, most of the patients
with such severe incontinence had been candidates for
dynamic graciloplasty at our institution . This means that,
in the event of an unsatisfactory functional outcome
despite a positive pelvic floor response during acute
testing , the patient would be a candidate for
dynamic graciloplasty, which could be applied by using the
previously implanted pulse generator.
We
conclude that, in our very preliminary experience, sacral
nerve stimulation has shown promising results in the
treatment of fecal incontinence of neurological etiology
as well as due to an idiopathic diffuse weakness of the
pelvic floor. Although a longer follow-up is mandatory to
assess the long-term efficacy of this method, the initial
promising results warrant further clinical studies
focusing on this new modality.
|
|
|
Literature
|
|
-
Madoff
RD, Baeten CGMI, Christiansen J,
et al. Standards for anal sphincter replacement.
Dis Colon Rectum 2000; 43:135-141
-
Baeten
CGMI, Geerdes BP, Adang EMM, Heineman E, et al. Anal
dynamic graciloplasty in the treatment of intractable
fecal Incontinence. N Engl J Med 1995; 332:1600-1605
-
Wong
WD, Jensen LL, Bartolo DCC, Rothenberger DA. Artificial
anal sphincter. Dis Colon Rectum 1996; 39: 1345-1351
-
Thon
WF, Baskin LS, Jonas U, et al. Neuromodulation of
voiding dysfunction and pelvic pain. World J Urol
1991; 9:138-141
-
Bosch
JLHR, Groen J. Sacral (S3) segmental nerve stimulation
as a treatment for urge incontinence in patients with
detrusor instability: results of chronic electrical
stimulation using an implantable neural prosthesis. J
Urol 1995; 154:504-507
-
Weil
EHJ, Riuz-Cerda JL, Eerdmans PHA, et al. Clinical
results of sacral neuromodulation for chronic voiding
dysfunction using unilateral sacral foramen electrodes.
World J Urol 1998; 16: 313-321
-
Ishigooka
M, Suzuki T, Hashimoto I, Sasagawa I, Nakada T, Handa
Y. A new technique for sacral nerve stimulation: a
percutaneous method for urinary incontinence caused by
spinal cord injury. Br J Urol 1998; 81:315-318
-
Caldwell
KPS the electrical control of sphincter incompetence. Lancet
1963; 2: 174 - 177
-
Matzel
KE, Stadelmaier U, Hohenfellner M. Gall FP. Electrical
stimulation of spinal nerves for treatment of fecal
incontinence. Lancet 1995;346:1124-1127
-
Vaizey
CJ, Kamm MA, Turner I, et al. effects of short term
sacral nerve stimulation on anal and rectal function
in patients with anal incontinence. Gut 1999;
44:407-412
-
Malouf
AJ, Vaizey CJ, Nicholls J, Kamm MA. Permanent
sacral nerve stimulation for fecal incontinence.
Ann Surg 2000; 232:143-148
-
Rosen
HR, Novi G, Zöch G, Feil W, Urbarz C, Schiessel R.
Restoration of anal sphincter function by single-stage
dynamic graciloplasty with a modified (split sling)
technique. Am J Surg 1998;175:187-193
|
|